Skip to main content
Premium Trial:

Request an Annual Quote

For the Kids

Premium

Researchers from St. Jude Children's Research Hospital and Washington University School of Medicine have published "the world's largest collection of genetic data on childhood cancers," reports BBC News' Emily Selvadurai. The researchers, who formed the US Pediatric Cancer Genome Project in 2010, mapped the whole germline genomes and cancer genomes of 260 pediatric cancer patients in an effort to find all the differences between their germline and tumor DNA. The work, which they discuss in Nature Genetics, has already led to a new treatment for retinoblastoma, Selvadurai says. The PCGP Consortium has also made its data available to researchers worldwide at the European Genome-phenome Archive website.

"We have identified unusual, 'cryptic' changes in many patients' cancer cells that we would not have found using other methods," says Richard Wilson, a member of the consortium and head of the Genome Institute at Washington University School of Medicine, in a statement. "We are pleased to be able to share this data with the research community in the hope that others can build upon our initial discoveries."

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.